Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 28, 2026; 32(16): 117259
Published online Apr 28, 2026. doi: 10.3748/wjg.v32.i16.117259
Published online Apr 28, 2026. doi: 10.3748/wjg.v32.i16.117259
Table 2 Clinical characteristics: Prediagnostic surgical vs non-surgical groups, %
| Characteristic | Total (n = 156) | Non-surgical group (n = 76) | Surgical group (n = 78) | P value |
| Male | 66 (102/155) | 70 (53/76) | 62 (48/77) | 0.334 |
| Female | 34 (53/155) | 30 (23/76) | 38 (29/77) | 0.334 |
| Clinical symptoms | ||||
| Abdominal pain | 60 (94/156) | 55 (42/76) | 65 (51/78) | 0.199 |
| Diarrhea | 38 (60/156) | 54 (41/76) | 24 (19/78) | < 0.001a |
| Constipation | 3 (5/156) | 3 (2/76) | 4 (3/78) | 0.671 |
| Vomiting | 9 (14/156) | 7 (5/76) | 12 (9/78) | 0.284 |
| Abdominal distension | 21 (32/156) | 22 (17/76) | 19 (15/78) | 0.631 |
| Hematochezia | 7 (11/156) | 8 (6/76) | 6 (5/78) | 0.721 |
| Fever | 41 (29/70) | 43 (16/37) | 41 (13/32) | 0.826 |
| Weight loss | 51 (79/156) | 66 (50/76) | 37 (29/78) | < 0.001a |
| Intestinal obstruction | 19 (30/156) | 20 (15/76) | 19 (15/78) | 0.937 |
| Intestinal perforation | 34 (53/156) | 14 (11/76) | 54 (42/78) | < 0.001a |
| Ascites | 6 (10/156) | 7 (5/76) | 6 (5/78) | 0.966 |
| Bleeding | 3 (4/156) | 5 (4/76) | 0 | 0.057 |
| Sites of involvement | ||||
| Stomach | 9 (13/152) | 14 (10/74) | 3 (2/76) | 0.016a |
| Small intestine | 86 (130/152) | 82 (61/74) | 88 (67/76) | 0.322 |
| Colon and rectum | 24 (36/152) | 35 (26/74) | 13 (10/76) | 0.002a |
| Laboratory findings | ||||
| Anemia | 61 (44/72) | 68 (27/40) | 53 (17/32) | 0.213 |
| Hypoalbuminemia | 89 (51/57) | 89 (32/36) | 90 (19/21) | 1.000 |
| Elevated CRP | 87 (34/39) | 87 (20/23) | 88 (14/16) | 1.000 |
| Pathological features | ||||
| CD2+ | 74 (20/27) | 86 (12/14) | 58 (7/12) | 0.190 |
| CD3+ | 99 (136/138) | 98 (61/62) | 99 (73/74) | 1.000 |
| CD4- | 81 (88/109) | 84 (41/49) | 78 (46/59) | 0.456 |
| CD5- | 86 (83/96) | 92 (35/38) | 82 (47/57) | 0.232 |
| CD7+ | 100 (58/58) | 100 (32/32) | 100 (25/25) | 1.000 |
| CD8+ | 90 (121/135) | 88 (57/65) | 91 (62/68) | 0.513 |
| CD56+ | 95 (129/136) | 94 (60/64) | 97 (68/70) | 0.425 |
| CD20+ | 13 (12/93) | 20 (7/35) | 9 (5/56) | 0.129 |
| TIA-1+ | 93 (65/70) | 80 (20/25) | 100 (43/43) | 0.005a |
| Granzyme B+ | 68 (40/59) | 50 (11/22) | 81 (29/36) | 0.015a |
- Citation: Jiang SJ, Ou CZ, Tang H, Li MH, Jia CW, Zhou WX, He ZYT, Li J, Zhang Y, Li JN. Monomorphic epitheliotropic intestinal T-cell lymphoma: Clinical, endoscopic and pathological features. World J Gastroenterol 2026; 32(16): 117259
- URL: https://www.wjgnet.com/1007-9327/full/v32/i16/117259.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i16.117259